Skip to main content

Ocugen to resume Covaxin trials 'immediately' after FDA lifts its latest clinical hold

The hold was put in place as a result of statements made by the World Health Organization after its inspection of Bharat Biotech's manufacturing facility.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.